Integral Diagnostics Ltd. (AU:IDX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Capitol Health Limited has received Federal Court approval for its merger with Integral Diagnostics Limited, set to become legally effective on December 11, 2024. Following this, Capitol’s shares will be suspended from trading on the ASX, and new Integral Diagnostics shares will begin trading on December 12, 2024. The merger aims to enhance diagnostic imaging services across Australia.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.